ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2017 American Transplant Congress

    Mycophenolate Dose Reductions Are Not Associated with De Novo Donor-Specific Antibodies.

    S. Davis, J. Gralla, P. Klem, A. Wiseman, J. Cooper.

    University of Colorado, Aurora, CO

    De novo donor-specific antibodies (dnDSA) are central to the development of antibody-mediated rejection, which is the most important cause of death-censored graft loss. It is…
  • 2017 American Transplant Congress

    Antioxidant Thermoresponsive Hydrogel as a Versatile Islets Scaffolds for Treating Type I Diabetes.

    Y. Zhu,1 X. Zhang,2 G. Ameer,1 X. Luo.2

    1McCormick School of Engineering, Northwestern University, Evanston, IL; 2Feinberg School of Medicine, Northwestern University, Chicago, IL

    Introduction: Hepatic islets transplantation procedure to treat type I diabetes often results in limited islets survival presumably due to uneven islet distribution, acute inflammatory response…
  • 2017 American Transplant Congress

    Successful Launch of an ABO-Incompatible Kidney Transplantation Program to Overcome the Shortage of Compatible Living Donors: Experience at a Single Center.

    S. Song,1 J. Lee,1 J. Lee,1 S.-K. Kwon,1 B. Kim,2,3 J. Lee,1 Y. Kim,1,3 M. Kim,1,3 S. Kim,1,3 K. Huh.1,3

    1Transplantation Surgery, Yonsei University Health System, Seoul, Republic of Korea; 2Nephrology, Yonsei University Health System, Seoul, Republic of Korea; 3The Research Institute for Transplantation, Yonsei University College of Medicine, Seoul, Republic of Korea

    Introduction:ABO-incompatible (ABOi) kidney transplantation (KT) is being increasingly performed to overcome donor shortages. However, debate persists regarding the post-transplant outcomes of ABOi KT versus that…
  • 2017 American Transplant Congress

    Which Way to Go, Liver Resection or Liver Transplantation for Hepatocellular Carcinoma in Child A Liver Cirrhosis.

    K. Yoon, K.-W. Lee, H. Kim, D. Oh, H.-S. Kim, S. Ahn, S. Hong, N.-J. Yi, K.-S. Suh.

    Department of Surgery, Seoul National University College of Medicine, Seoul, Jongrogu, Republic of Korea

    Introduction: Hepatocellular carcinoma(HCC) has high recurrence rate after liver resection(LR). The recurrence within Milan after LR is only 61- 79% in patient with child A.…
  • 2017 American Transplant Congress

    Program-Specific Offer Acceptance Behavior for Kidney Programs Across the Spectrum of KDPI.

    A. Wey, N. Salkowski, B. Kasiske, A. Israni, J. Snyder.

    Scientific Registry of Transplant Recipients, Minneapolis, MN

    Little is known about the offer acceptance behavior of kidney transplant programs, which affects rates of discard and access to transplant. An offer acceptance model…
  • 2017 American Transplant Congress

    The Use of Kidneys from Deceased Donors Over 80 Years in Kidney Transplantation.

    M. Pérez-Sáez,1 E. Arcos,2 J. Comas,2 J. Pascual.1

    1Nephrology, Hospital del Mar, Barcelona, Spain; 2Organització Catalana de Trasplantaments, Barcelona, Spain

    Patient survival is longer after kidney transplantation (KT) compared with remaining in the waiting list on dialysis. We have questioned if this is true also…
  • 2017 American Transplant Congress

    Clusterin Levels at 3-Months Associate with DGF and 12-Month Fibrosis – Reinforcing the Early Injury to Fibrosis Continuum.

    M. Menon,1 L. Liriano-Ward,2 N. Philippe,1 C. Wei,1 W. Zhang,1 Z. Yi,1 K. Keung,2 P. O'Connell,2 B. Murphy.1

    1Medicine, Nephrology, Icahn School of Medicine at Mount Sinai, New York, NY; 2Medicine, Westmead Millenium Institute, Sydney, NSW, Australia

    The Genomics of Chronic Allograft Rejection (GoCAR) is a multicenter study investigating the ability of gene expression to predict the development of Chronic allograft nephropathy.…
  • 2017 American Transplant Congress

    Immunosuppressive Treatment Alters Gut Microbiota and Modified Gut Microbiota Affects Immune Status.

    Z. Zhang, Y. Xu, Q. Zhang, X. Hu.

    Department of Urology, Beijing Chaoyang Hospital, CCMU, Beijing, China

    Objectives: Immunosuppressive therapies could change the host-microbial interactions, especially gut microbiota, which is an important component in systemic immunity. We evaluated the relationship between immunosuppression…
  • 2017 American Transplant Congress

    Twelve Hour Ex Vivo Normothermic Perfusion for the Assessment of High-Risk Discarded Deceased Donor Kidneys.

    I. Palma, I. Palma, Y. Smolin, S. Kabagambe, A. Perry, J. Sageshima, R. Perez.

    Department of Surgery, UC Davis Medical Center, Sacramento, CA

    Ex-Vivo Normothermic Perfusion (EVNP) has been shown to be useful to assess viability of high-risk deceased donor kidneys, with high renal blood flow and immediate…
  • 2017 American Transplant Congress

    Protective Effects of Bryostatin-1 on Neutrophil Migration in an In Vitro Model of Ischemia Reperfusion Injury: Impact for Therapy.

    F. Becker,1 L. Kebschull,1 T. Castor,3 D. Palmes,2 S. Alexander,2 F. Gavins.2

    1Department for General and Visceral Surgery, University Hospital Münster, Münster, Germany; 2Department of Molecular and Cellular Physiology, Department of Molecular and Cellular Physiology, Shreveport, LA; 3Aphios Corporation, Woburn, MA

    Background: Ischemia-reperfusion injury (IRI) is an inherent component of solid organ transplantation and axiomatically linked to graft damage. In the kidney, IRI results in a…
  • « Previous Page
  • 1
  • …
  • 14
  • 15
  • 16
  • 17
  • 18
  • …
  • 181
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences